{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:53:35Z","timestamp":1790801615933,"version":"4.1.0"},"reference-count":202,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK090964"],"award-info":[{"award-number":["DK090964"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK114711"],"award-info":[{"award-number":["DK114711"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is the number one chronic liver disease worldwide and is estimated to affect nearly 40% of obese youth and up to 10% of the general pediatric population without any obvious signs or symptoms. Although the early stages of NAFLD are reversible with diet and lifestyle modifications, detecting such stages is hindered by a lack of non-invasive methods of risk assessment and diagnosis. This absence of non-invasive means of diagnosis is directly related to the scarcity of long-term prospective studies of pediatric NAFLD in children and adolescents. In the majority of pediatric NAFLD cases, the mechanisms driving the origin and rapid progression of NAFLD remain unknown. The progression from NAFLD to non-alcoholic steatohepatitis (NASH) in youth is associated with unique histological features and possible immune processes and metabolic pathways that may reflect different mechanisms compared with adults. Recent data suggest that circulating microRNAs (miRNAs) are important new biomarkers underlying pathways of liver injury. Several factors may contribute to pediatric NAFLD development, including high-sugar diets, in utero exposures via epigenetic alterations, changes in the neonatal microbiome, and altered immune system development and mitochondrial function. This review focuses on the unique aspects of pediatric NAFLD and how nutritional exposures impact the immune system, mitochondria, and liver\/gastrointestinal metabolic health. These factors highlight the need for answers to how NAFLD develops in children and for early stage-specific interventions.<\/jats:p>","DOI":"10.3390\/nu12103166","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T08:56:48Z","timestamp":1602838608000},"page":"3166","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Pediatric Non-Alcoholic Fatty Liver Disease: Nutritional Origins and Potential Molecular Mechanisms"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3473-2456","authenticated-orcid":false,"given":"Ashok","family":"Mandala","sequence":"first","affiliation":[{"name":"Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel C.","family":"Janssen","sequence":"additional","affiliation":[{"name":"Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirish","family":"Palle","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Gastroenterology, Hepatology &amp; Nutrition, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"Short","sequence":"additional","affiliation":[{"name":"Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"},{"name":"Department of Pediatrics, Section of Diabetes and Endocrinology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"},{"name":"Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-1512","authenticated-orcid":false,"given":"Jacob E.","family":"Friedman","sequence":"additional","affiliation":[{"name":"Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"},{"name":"Department of Pediatrics, Section of Diabetes and Endocrinology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"},{"name":"Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/liv.13301","article-title":"Pathology of non-alcoholic fatty liver disease","volume":"37","author":"Bedossa","year":"2017","journal-title":"Liver Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease\u2014A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"65","author":"Fazel","year":"2016","journal-title":"Metabolism"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Anderson, E.L., Howe, L.D., Jones, H.E., Higgins, J.P., Lawlor, D.A., and Fraser, A. (2015). The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140908"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4254\/wjh.v9.i2.69","article-title":"From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease","volume":"9","author":"Umano","year":"2017","journal-title":"World J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pacifico, L., Perla, F.M., Roggini, M., Andreoli, G., D\u2019Avanzo, M., and Chiesa, C. (2019). A systematic review of NAFLD-associated extrahepatic disorders in youths. J. Clin. Med., 8.","DOI":"10.3390\/jcm8060868"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jpeds.2020.03.038","article-title":"Glomerular hyperfiltration is associated with liver disease severity in children with nonalcoholic fatty liver disease","volume":"222","author":"Yodoshi","year":"2020","journal-title":"J. Pediatr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrgastro.2016.160","article-title":"Developmental origins of NAFLD: A womb with a clue","volume":"14","author":"Wesolowski","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/qjmed\/hcp158","article-title":"Pathogenesis of non-alcoholic fatty liver disease","volume":"103","author":"Dowman","year":"2010","journal-title":"QJM"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_14","unstructured":"(2020, September 10). AAP Endorses New Guidelines on Non-Alcoholic Fatty Liver Disease. Available online: https:\/\/www.aappublications.org\/news\/2016\/12\/02\/FattyLiver120216."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.27395","article-title":"The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease","volume":"61","author":"Maximos","year":"2015","journal-title":"Hepatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s10620-015-3614-z","article-title":"Circulating soluble Fas and Fas ligand levels are elevated in children with nonalcoholic steatohepatitis","volume":"60","author":"Alkhouri","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Becker, P.P., Rau, M., Schmitt, J., Malsch, C., Hammer, C., Bantel, H., Mullhaupt, B., and Geier, A. (2015). Performance of serum microRNAs -122, -192 and -21 as biomarkers in patients with non-alcoholic steatohepatitis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142661"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.metabol.2016.01.013","article-title":"Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?","volume":"65","author":"Alkhouri","year":"2016","journal-title":"Metabolism"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/hep.28860","article-title":"Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood","volume":"65","author":"Decaris","year":"2017","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12944-017-0551-1","article-title":"Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: A case\u2014Control study","volume":"16","author":"Feng","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9729107","DOI":"10.1155\/2017\/9729107","article-title":"Diagnostic value of CK-18, FGF-21, and related biomarker panel in nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"2017","author":"He","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00125-017-4340-1","article-title":"Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: A population-based and inter-laboratory study","volume":"60","author":"Isokuortti","year":"2017","journal-title":"Diabetologia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"E266","DOI":"10.1152\/ajpendo.00262.2017","article-title":"The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans","volume":"314","author":"Peter","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00535-017-1414-2","article-title":"Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods","volume":"53","author":"Yoneda","year":"2018","journal-title":"J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.metabol.2016.01.008","article-title":"Similarities and differences between pediatric and adult nonalcoholic fatty liver disease","volume":"65","author":"Crespo","year":"2016","journal-title":"Metabolism"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: New genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11894-015-0447-z","article-title":"A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease","volume":"17","author":"Mansoor","year":"2015","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00247-011-2257-2","article-title":"Acoustic radiation force impulse-imaging in the assessment of liver fibrosis in children","volume":"42","author":"Noruegas","year":"2012","journal-title":"Pediatr. Radiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40477-016-0229-y","article-title":"Liver acoustic radiation force impulse (ARFI) in childhood obesity: Comparison and correlation with biochemical markers","volume":"20","author":"Kamble","year":"2017","journal-title":"J. Ultrasound"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ferraioli, G., Calcaterra, V., Lissandrin, R., Guazzotti, M., Maiocchi, L., Tinelli, C., De Silvestri, A., Regalbuto, C., Pelizzo, G., and Larizza, D. (2017). Noninvasive assessment of liver steatosis in children: The clinical value of controlled attenuation parameter. BMC Gastroenterol., 17.","DOI":"10.1186\/s12876-017-0617-6"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrgastro.2018.10","article-title":"Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD","volume":"15","author":"Tapper","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pharmthera.2018.04.005","article-title":"Bile acid regulation: A novel therapeutic strategy in non-alcoholic fatty liver disease","volume":"190","author":"Yu","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","article-title":"Plasma metabolomic profile in nonalcoholic fatty liver disease","volume":"60","author":"Kalhan","year":"2011","journal-title":"Metabolism"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jc.2006-1010","article-title":"Alanine aminotransferase levels and fatty liver in childhood obesity: Associations with insulin resistance, adiponectin, and visceral fat","volume":"91","author":"Burgert","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cheng, S., Wiklund, P., Autio, R., Borra, R., Ojanen, X., Xu, L., T\u00f6rm\u00e4kangas, T., and Alen, M. (2015). Adipose tissue dysfunction and altered systemic amino acid metabolism are associated with non-alcoholic fatty liver disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0138889"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e1426","DOI":"10.1542\/peds.2007-0189","article-title":"Fasting nonesterified fatty acid profiles in childhood and their relationship with adiposity, insulin sensitivity, and lipid levels","volume":"120","author":"Sabin","year":"2007","journal-title":"Pediatrics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e127737","DOI":"10.1172\/jci.insight.127737","article-title":"Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver","volume":"5","author":"Fletcher","year":"2019","journal-title":"JCI Insight"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2337\/db10-0554","article-title":"Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents","volume":"59","author":"Goran","year":"2010","journal-title":"Diabetes"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2337\/dc12-1791","article-title":"The association between hepatic fat content and liver injury in obese children and adolescents: Effects of ethnicity, insulin resistance, and common gene variants","volume":"36","author":"Santoro","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"E1125","DOI":"10.1210\/jc.2015-1587","article-title":"Hepatic de novo lipogenesis in obese youth is modulated by a common variant in the GCKR gene","volume":"100","author":"Santoro","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.28283","article-title":"Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study","volume":"63","author":"Goffredo","year":"2016","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.dld.2016.04.014","article-title":"Reduced lysosomal acid lipase activity-A potential role in the pathogenesis of non alcoholic fatty liver disease in pediatric patients","volume":"48","author":"Selvakumar","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Tovoli, F., Napoli, L., Negrini, G., D\u2019Addato, S., Tozzi, G., D\u2019Amico, J., Piscaglia, F., and Bolondi, L. (2017). A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061134"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1111\/liv.14206","article-title":"Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease","volume":"39","author":"Baratta","year":"2019","journal-title":"Liver Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.3748\/wjg.v25.i30.4172","article-title":"Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease?","volume":"25","author":"Baratta","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/jn\/nxaa183","article-title":"A low \u03c9-6 to \u03c9-3 PUFA ratio (n-6:n-3 PUFA) diet to treat fatty liver disease in obese youth","volume":"150","author":"Savoye","year":"2020","journal-title":"J. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3945\/jn.117.248948","article-title":"Maternal dietary patterns during pregnancy are associated with newborn body composition","volume":"147","author":"Starling","year":"2017","journal-title":"J. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrendo.2013.108","article-title":"The obesogenic effect of high fructose exposure during early development","volume":"9","author":"Goran","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"203474","DOI":"10.1155\/2014\/203474","article-title":"Early life exposure to fructose and offspring phenotype: Implications for long term metabolic homeostasis","volume":"2014","author":"Sloboda","year":"2014","journal-title":"J. Obes."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bj.2018.02.006","article-title":"Translational insights on developmental origins of metabolic syndrome: Focus on fructose consumption","volume":"41","author":"Lee","year":"2018","journal-title":"Biomed. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1210\/jc.2010-2007","article-title":"A dual sugar challenge test for lipogenic sensitivity to dietary fructose","volume":"96","author":"Hudgins","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"E126","DOI":"10.1152\/ajpendo.00470.2017","article-title":"Dose-dependent quantitative effects of acute fructose administration on hepatic de novo lipogenesis in healthy humans","volume":"315","author":"Beysen","year":"2018","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1172\/JCI94585","article-title":"Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling","volume":"127","author":"Softic","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.cmet.2019.09.003","article-title":"Dietary sugars alter hepatic fatty acid oxidation via transcriptional and post-translational modifications of mitochondrial proteins","volume":"30","author":"Softic","year":"2019","journal-title":"Cell Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/oby.21371","article-title":"Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome","volume":"24","author":"Lustig","year":"2016","journal-title":"Obesity"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.gastro.2017.05.043","article-title":"Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity","volume":"153","author":"Schwarz","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1001\/jama.2018.20579","article-title":"Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: A randomized clinical trial","volume":"321","author":"Schwimmer","year":"2019","journal-title":"JAMA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e12630","DOI":"10.1111\/ijpo.12630","article-title":"Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial","volume":"15","author":"Goss","year":"2020","journal-title":"Pediatr. Obes."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1053\/jhep.2003.50132","article-title":"Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis","volume":"37","author":"Musso","year":"2003","journal-title":"Hepatology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n \u2212 6\/n \u2212 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"Araya","year":"2004","journal-title":"Clin. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pharmthera.2017.07.007","article-title":"Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease","volume":"181","author":"Jump","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MOL.0b013e3282ffaf6a","article-title":"N-3 polyunsaturated fatty acid regulation of hepatic gene transcription","volume":"19","author":"Jump","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/adc.2010.192401","article-title":"Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: Double-blind randomised controlled clinical trial","volume":"96","author":"Nobili","year":"2011","journal-title":"Arch. Dis. Child"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.jpeds.2015.01.056","article-title":"Omega-3 fatty acids therapy in children with nonalcoholic fatty liver disease: A randomized controlled trial","volume":"166","author":"Janczyk","year":"2015","journal-title":"J. Pediatr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4274\/jcrpe.1749","article-title":"Long-term treatment with n-3 polyunsaturated fatty acids as a monotherapy in children with nonalcoholic fatty liver disease","volume":"7","author":"Boyraz","year":"2015","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1126\/science.1104343","article-title":"Mitochondrial dysfunction and type 2 diabetes","volume":"307","author":"Lowell","year":"2005","journal-title":"Science"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.freeradbiomed.2011.12.014","article-title":"Metabolic syndrome and mitochondrial dysfunction: Insights from preclinical studies with a mitochondrially targeted antioxidant","volume":"52","author":"Mitchell","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.bbadis.2016.06.015","article-title":"Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in neurodegeneration","volume":"1863","author":"Jha","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(99)80033-6","article-title":"Mitochondrial abnormalities in non-alcoholic steatohepatitis","volume":"31","author":"Caldwell","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.3748\/wjg.v20.i15.4335","article-title":"Pediatric non-alcoholic steatohepatitis: The first report on the ultrastructure of hepatocyte mitochondria","volume":"20","author":"Lotowska","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI82204","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"125","author":"Satapati","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1038\/s41467-020-16092-0","article-title":"Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis","volume":"11","author":"An","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1113\/jphysiol.2009.169060","article-title":"Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury","volume":"587","author":"Thyfault","year":"2009","journal-title":"J. Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","article-title":"Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model","volume":"52","author":"Rector","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Ferro, D., Baratta, F., Pastori, D., Cocomello, N., Colantoni, A., Angelico, F., and Del Ben, M. (2020). New insights into the pathogenesis of non-alcoholic fatty liver disease: Gut-derived lipopolysaccharides and oxidative stress. Nutrients, 12.","DOI":"10.3390\/nu12092762"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3892\/ijmm_00000487","article-title":"Oxidative stress parameters in paediatric non-alcoholic fatty liver disease","volume":"26","author":"Nobili","year":"2010","journal-title":"Int. J. Mol. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/ars.2018.7704","article-title":"The antioxidant effects of hydroxytyrosol and vitamin E on pediatric nonalcoholic fatty liver disease, in a clinical trial: A new treatment?","volume":"31","author":"Nobili","year":"2019","journal-title":"Antioxid. Redox Signal."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Negri, R., Trinchese, G., Carbone, F., Caprio, M.G., Stanzione, G., di Scala, C., Micillo, T., Perna, F., Tarotto, L., and Gelzo, M. (2020). Randomised clinical trial: Calorie restriction regimen with tomato juice supplementation ameliorates oxidative stress and preserves a proper immune surveillance modulating mitochondrial bioenergetics of T-lymphocytes in obese children affected by non-alcoholic fatty liver disease (NAFLD). J. Clin. Med., 9.","DOI":"10.3390\/jcm9010141"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jnutbio.2018.03.025","article-title":"Non-alcoholic fatty liver disease severity and metabolic complications in obese children: Impact of omega-3 fatty acids","volume":"58","author":"Spahis","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.redox.2014.08.009","article-title":"The role of reactive oxygen species (ROS) and cytochrome P-450 2E1 in the generation of carcinogenic etheno-DNA adducts","volume":"3","author":"Linhart","year":"2014","journal-title":"Redox Biol."},{"key":"ref_85","first-page":"117","article-title":"The generation of carcinogenic etheno-DNA adducts in the liver of patients with nonalcoholic fatty liver disease","volume":"4","author":"Linhart","year":"2015","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_86","first-page":"426","article-title":"Detection of carcinogenic etheno-DNA adducts in children and adolescents with non-alcoholic steatohepatitis (NASH)","volume":"4","author":"Teufel","year":"2015","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fendo.2019.00611","article-title":"Gut dysfunction and non-alcoholic fatty liver disease","volume":"10","author":"Grabherr","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cld.2015.10.012","article-title":"Nonalcoholic fatty liver disease and the gut microbiome","volume":"20","author":"Boursier","year":"2016","journal-title":"Clin. Liver Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1053\/j.gastro.2019.06.028","article-title":"Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease","volume":"157","author":"Schwimmer","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3164\/jcbn.09-50","article-title":"Development of fibrosis in nonalcoholic steatosis through combination of a synthetic diet rich in disaccharide and low-dose lipopolysaccharides in the livers of Zucker (fa\/fa) rats","volume":"45","author":"Fukunishi","year":"2009","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","article-title":"Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling","volume":"16","author":"Imajo","year":"2012","journal-title":"Cell Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.3748\/wjg.v18.i21.2609","article-title":"Leaky gut and the liver: A role for bacterial translocation in nonalcoholic steatohepatitis","volume":"18","author":"Ilan","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3945\/ajcn.112.057331","article-title":"Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates","volume":"98","author":"Kavanagh","year":"2013","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1038\/s41598-017-06885-7","article-title":"Dietary patterns reflecting healthy food choices are associated with lower serum LPS activity","volume":"7","author":"Ahola","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Pastori, D., Carnevale, R., Nocella, C., Novo, M., Santulli, M., Cammisotto, V., Menichelli, D., Pignatelli, P., and Violi, F. (2017). Gut-derived serum lipopolysaccharide is associated with enhanced risk of major adverse cardiovascular events in atrial fibrillation: Effect of adherence to mediterranean diet. J. Am. Heart Assoc., 6.","DOI":"10.1161\/JAHA.117.005784"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jnutbio.2009.05.006","article-title":"Dietary fructose and intestinal barrier: Potential risk factor in the pathogenesis of nonalcoholic fatty liver disease","volume":"20","author":"Spruss","year":"2009","journal-title":"J. Nutr. Biochem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/hep.26299","article-title":"Dietary fructose in nonalcoholic fatty liver disease","volume":"57","author":"Vos","year":"2013","journal-title":"Hepatology"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/ajcn\/86.5.1286","article-title":"A high-fat meal induces low-grade endotoxemia: Evidence of a novel mechanism of postprandial inflammation","volume":"86","author":"Erridge","year":"2007","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2337\/dc09-1630","article-title":"Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of Toll-like receptor-4 and suppressor of cytokine signaling-3","volume":"33","author":"Deopurkar","year":"2010","journal-title":"Diabetes Care"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/ajcn\/87.5.1219","article-title":"Energy intake is associated with endotoxemia in apparently healthy men","volume":"87","author":"Amar","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.dld.2014.02.010","article-title":"Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity","volume":"46","author":"Giorgio","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Nier, A., Engstler, A.J., Maier, I.B., and Bergheim, I. (2017). Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0183282"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Nier, A., Brandt, A., Conzelmann, I.B., \u00d6zel, Y., and Bergheim, I. (2018). Non-alcoholic fatty liver disease in overweight children: Role of fructose intake and dietary pattern. Nutrients, 10.","DOI":"10.3390\/nu10091329"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/j.1572-0241.2002.05791.x","article-title":"Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia","volume":"97","author":"Bauer","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1111\/j.1572-0241.2001.04668.x","article-title":"Small intestinal bacterial overgrowth in patients with cirrhosis: Prevalence and relation with spontaneous bacterial peritonitis","volume":"96","author":"Bauer","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1476-9255-7-15","article-title":"Elevated endotoxin levels in non-alcoholic fatty liver disease","volume":"7","author":"Harte","year":"2010","journal-title":"J. Inflamm."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/apt.13327","article-title":"Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: A prospective cohort study","volume":"42","author":"Wong","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/db14-1213","article-title":"Short-chain fatty acids protect against high-fat diet-induced obesity via a PPAR\u03b3-dependent switch from lipogenesis to fat oxidation","volume":"64","author":"Bleeker","year":"2015","journal-title":"Diabetes"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cell.2016.04.055","article-title":"Maternal IgG and IgA antibodies dampen mucosal T helper cell responses in early life","volume":"165","author":"Koch","year":"2016","journal-title":"Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.immuni.2016.02.006","article-title":"Gut microbiota-induced immunoglobulin G controls systemic infection by symbiotic bacteria and pathogens","volume":"44","author":"Zeng","year":"2016","journal-title":"Immunity"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"307ra152","DOI":"10.1126\/scitranslmed.aab2271","article-title":"Early infancy microbial and metabolic alterations affect risk of childhood asthma","volume":"7","author":"Arrieta","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00018-017-2670-2","article-title":"Early microbiota, antibiotics and health","volume":"75","author":"Nogacka","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/gmic.26489","article-title":"Proteobacteria-specific IgA regulates maturation of the intestinal microbiota","volume":"5","author":"Mirpuri","year":"2014","journal-title":"Gut Microbes"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41385-020-0257-y","article-title":"Imprinting of the immune system by the microbiota early in life","volume":"13","author":"Eberl","year":"2020","journal-title":"Mucosal Immunol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.cell.2016.04.007","article-title":"Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans","volume":"165","author":"Vatanen","year":"2016","journal-title":"Cell"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/MPG.0000000000000597","article-title":"Why is initial bacterial colonization of the intestine important to infants\u2019 and children\u2019s health?","volume":"60","author":"Houghteling","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3945\/ajcn.115.126375","article-title":"Alterations in human milk leptin and insulin are associated with early changes in the infant intestinal microbiome","volume":"103","author":"Lemas","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1038\/s41467-018-06929-0","article-title":"The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD","volume":"9","author":"Soderborg","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"102","DOI":"10.15698\/mic2019.01.666","article-title":"Imbalance in gut microbes from babies born to obese mothers increases gut permeability and myeloid cell adaptations that provoke obesity and NAFLD","volume":"6","author":"Soderborg","year":"2018","journal-title":"Microb. Cell"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/apt.15314","article-title":"Review article: Emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications","volume":"50","author":"Jayakumar","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1093\/eurheartj\/ehw146","article-title":"Liver microRNAs: Potential mediators and biomarkers for metabolic and cardiovascular disease?","volume":"37","author":"Willeit","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4161\/rna.20378","article-title":"Small RNAs have a large impact: Circulating microRNAs as biomarkers for human diseases","volume":"9","author":"Weiland","year":"2012","journal-title":"RNA Biol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: From serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1053\/j.gastro.2017.08.013","article-title":"Metabolic circuit involving free fatty acids, microRNA 122, and triglyceride synthesis in liver and muscle tissues","volume":"153","author":"Chai","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Yu, J., Peng, J., Luan, Z., Zheng, F., and Su, W. (2019). MicroRNAs as a novel tool in the diagnosis of liver lipid dysregulation and fatty liver disease. Molecules, 24.","DOI":"10.3390\/molecules24020230"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","article-title":"Extracellular miRNAs: From biomarkers to mediators of physiology and disease","volume":"30","author":"Mori","year":"2019","journal-title":"Cell Metab."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Lin, H.Y., Yang, Y.L., Wang, P.W., Wang, F.S., and Huang, Y.H. (2020). The emerging role of microRNAs in NAFLD: Highlight of microRNA-29a in modulating oxidative stress, inflammation, and beyond. Cells, 9.","DOI":"10.3390\/cells9041041"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/rna.1.2.1066","article-title":"miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1","volume":"1","author":"Chang","year":"2004","journal-title":"RNA Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/1091581817704975","article-title":"Comprehensive analysis of circulating microRNA specific to the liver, heart, and skeletal muscle of cynomolgus monkeys","volume":"36","author":"Iguchi","year":"2017","journal-title":"Int. J. Toxicol."},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Tan, Y., Ge, G., Pan, T., Wen, D., and Gan, J. (2014). A pilot study of serum microRNAs panel as potential biomarkers for diagnosis of nonalcoholic fatty liver disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0105192"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s10020-019-0085-2","article-title":"miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease","volume":"25","author":"Long","year":"2019","journal-title":"Mol. Med."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Povero, D., Eguchi, A., Li, H., Johnson, C.D., Papouchado, B.G., Wree, A., Messer, K., and Feldstein, A.E. (2014). Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0113651"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ijpo.12261","article-title":"Circulating levels of miR-122 and nonalcoholic fatty liver disease in pre-pubertal obese children","volume":"13","author":"Brandt","year":"2018","journal-title":"Pediatr. Obes."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic microRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/liv.13097","article-title":"Deregulated hepatic microRNAs underlie the association between non-alcoholic fatty liver disease and coronary artery disease","volume":"36","author":"Molina","year":"2016","journal-title":"Liver Int."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1111\/liv.12429","article-title":"Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease","volume":"34","author":"Miyaaki","year":"2014","journal-title":"Liver Int."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15252\/embr.201541930","article-title":"Reversible HuR-microRNA binding controls extracellular export of miR-122 and augments stress response","volume":"17","author":"Mukherjee","year":"2016","journal-title":"EMBO Rep."},{"key":"ref_141","first-page":"541","article-title":"Ultrasound-assisted miR-122-loaded polymeric nanodroplets for hepatocellular carcinoma gene therapy","volume":"17","author":"Guo","year":"2020","journal-title":"Mol. Pharm."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1021\/acsami.9b00634","article-title":"Delivery of liver-specific miRNA-122 using a targeted macromolecular prodrug toward synergistic therapy for hepatocellular carcinoma","volume":"11","author":"Ning","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.31050","article-title":"Lipotoxic hepatocyte-derived exosomal microRNA 192-5p activates macrophages through rictor\/Akt\/forkhead box transcription factor O1 signaling in nonalcoholic fatty liver disease","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"E407","DOI":"10.1210\/jc.2014-2574","article-title":"Circulating miR-192 and miR-193b are markers of prediabetes and are modulated by an exercise intervention","volume":"100","author":"Brugnara","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.3748\/wjg.v23.i46.8140","article-title":"miR-192-5p regulates lipid synthesis in non-alcoholic fatty liver disease through SCD-1","volume":"23","author":"Liu","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1159\/000447917","article-title":"Decreased miR-155 level in the peripheral blood of non-alcoholic fatty liver disease patients may serve as a biomarker and may influence LXR activity","volume":"39","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"16774","DOI":"10.1038\/srep16774","article-title":"Isocaloric pair-fed high-carbohydrate diet induced more hepatic steatosis and inflammation than high-fat diet mediated by miR-34a\/SIRT1 axis in mice","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"102697","DOI":"10.1016\/j.ebiom.2020.102697","article-title":"Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes","volume":"53","author":"Latorre","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1007\/s00535-016-1178-0","article-title":"A micro-RNA expression signature for human NAFLD progression","volume":"51","author":"Guo","year":"2016","journal-title":"J. Gastroenterol."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023937"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1136\/gutjnl-2015-309456","article-title":"Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: A prospective study","volume":"65","author":"Zarrinpar","year":"2016","journal-title":"Gut"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"E911","DOI":"10.1152\/ajpendo.00190.2019","article-title":"Micro-RNA-27a\/b negatively regulates hepatic gluconeogenesis by targeting FOXO1","volume":"317","author":"Wang","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/labinvest.2010.166","article-title":"Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease","volume":"91","author":"Alisi","year":"2011","journal-title":"Lab. Investig."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ijpo.12050","article-title":"The investigation of circulating microRNAs associated with lipid metabolism in childhood obesity","volume":"11","author":"Can","year":"2016","journal-title":"Pediatr. Obes."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1172\/JCI75438","article-title":"MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids","volume":"125","author":"Fu","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Xu, H., Tian, Y., Tang, D., Zou, S., Liu, G., Song, J., Zhang, G., Du, X., Huang, W., and He, B. (2020). An endoplasmic reticulum stress-microRNA-26a feedback circuit in nonalcoholic fatty liver disease. Hepatology.","DOI":"10.1002\/hep.31428"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Shah, K.B., Chernausek, S.D., Teague, A.M., Bard, D.E., and Tryggestad, J.B. (2020). Maternal diabetes alters microRNA expression in fetal exosomes, human umbilical vein endothelial cells and placenta. Pediatr. Res.","DOI":"10.1038\/s41390-020-1060-x"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1042\/CS20160305","article-title":"Influence of gestational diabetes mellitus on human umbilical vein endothelial cell miRNA","volume":"130","author":"Tryggestad","year":"2016","journal-title":"Clin. Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbrc.2017.04.099","article-title":"Role of microRNA-130b in placental PGC-1alpha\/TFAM mitochondrial biogenesis pathway","volume":"487","author":"Jiang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1700082","DOI":"10.1002\/mnfr.201700082","article-title":"Human milk exosomes and their microRNAs survive digestion in vitro and are taken up by human intestinal cells","volume":"61","author":"Liao","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/1541-4337.12424","article-title":"Milk microRNAs in health and disease","volume":"18","author":"Benmoussa","year":"2019","journal-title":"Compr. Rev. Food Sci. F"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"R528","DOI":"10.1152\/ajpregu.00316.2007","article-title":"Maternal obesity at conception programs obesity in the offspring","volume":"294","author":"Shankar","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1203\/PDR.0b013e318225f9b1","article-title":"The influence of maternal body mass index on infant adiposity and hepatic lipid content","volume":"70","author":"Modi","year":"2011","journal-title":"Pediatr. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jpeds.2012.11.017","article-title":"Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes","volume":"162","author":"Brumbaugh","year":"2013","journal-title":"J. Pediatr."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpeds.2017.03.007","article-title":"Low and high birth weights are risk factors for nonalcoholic fatty liver disease in children","volume":"187","author":"Newton","year":"2017","journal-title":"J. Pediatr."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"495.e491\u2013e498","DOI":"10.1016\/j.ajog.2010.06.042","article-title":"Maternal high-fat intake predisposes nonalcoholic fatty liver disease in C57BL\/6 offspring","volume":"203","author":"Gregorio","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jhep.2009.12.042","article-title":"Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in mice","volume":"52","author":"Oben","year":"2010","journal-title":"J. Hepatol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/hep.23205","article-title":"Maternal high-fat feeding primes steatohepatitis in adult mice offspring, involving mitochondrial dysfunction and altered lipogenesis gene expression","volume":"50","author":"Bruce","year":"2009","journal-title":"Hepatology"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.26248","article-title":"Maternal obesity programs offspring nonalcoholic fatty liver disease by innate immune dysfunction in mice","volume":"58","author":"Mouralidarane","year":"2013","journal-title":"Hepatology"},{"key":"ref_170","first-page":"323","article-title":"Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates","volume":"119","author":"McCurdy","year":"2009","journal-title":"J. Clin. Investig."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Igosheva, N., Abramov, A.Y., Poston, L., Eckert, J.J., Fleming, T.P., Duchen, M.R., and McConnell, J. (2010). Maternal diet-induced obesity alters mitochondrial activity and redox status in mouse oocytes and zygotes. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010074"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Borengasser, S.J., Lau, F., Kang, P., Blackburn, M.L., Ronis, M.J., Badger, T.M., and Shankar, K. (2011). Maternal obesity during gestation impairs fatty acid oxidation and mitochondrial SIRT3 expression in rat offspring at weaning. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024068"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jnutbio.2011.12.008","article-title":"Maternal high-fat intake during pregnancy programs metabolic-syndrome-related phenotypes through liver mitochondrial DNA copy number and transcriptional activity of liver PPARGC1A","volume":"24","author":"Cabrerizo","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1242\/dev.114850","article-title":"Mitochondrial dysfunction in oocytes of obese mothers: Transmission to offspring and reversal by pharmacological endoplasmic reticulum stress inhibitors","volume":"142","author":"Wu","year":"2015","journal-title":"Development"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.2337\/db14-0276","article-title":"Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates","volume":"63","author":"Thorn","year":"2014","journal-title":"Diabetes"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"R26","DOI":"10.1152\/ajpregu.00049.2014","article-title":"Oxidative stress and altered lipid homeostasis in the programming of offspring fatty liver by maternal obesity","volume":"307","author":"Alfaradhi","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jnutbio.2010.12.011","article-title":"Maternal high-fat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver","volume":"23","author":"Ashino","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.4049\/jimmunol.1700434","article-title":"Maternal pregravid obesity remodels the DNA methylation landscape of cord blood monocytes disrupting their inflammatory program","volume":"199","author":"Sureshchandra","year":"2017","journal-title":"J. Immunol."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Wankhade, U.D., Zhong, Y., Kang, P., Alfaro, M., Chintapalli, S.V., Thakali, K.M., and Shankar, K. (2017). Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175675"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1172\/JCI127502","article-title":"Parental metabolic syndrome epigenetically reprograms offspring hepatic lipid metabolism in mice","volume":"130","author":"Orime","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1096\/fj.12-212878","article-title":"A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates","volume":"26","author":"Suter","year":"2012","journal-title":"FASEB J."},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"de Oliveira, F.L., Panera, N., De Stefanis, C., Mosca, A., D\u2019Oria, V., Crudele, A., De Vito, R., Nobili, V., and Alisi, A. (2019). The number of liver galectin-3 positive cells is dually correlated with NAFLD severity in children. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143460"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Carpino, G., Nobili, V., Renzi, A., De Stefanis, C., Stronati, L., Franchitto, A., Alisi, A., Onori, P., De Vito, R., and Alpini, G. (2016). Macrophage activation in pediatric nonalcoholic fatty liver disease (NAFLD) correlates with hepatic progenitor cell response via Wnt3a pathway. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157246"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/00365521.2012.746390","article-title":"The role of Kupffer cells in the morphogenesis of nonalcoholic steatohepatitis - ultrastructural findings. The first report in pediatric patients","volume":"48","author":"Lotowska","year":"2013","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jhep.2013.12.025","article-title":"Macrophage heterogeneity in liver injury and fibrosis","volume":"60","author":"Tacke","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/hep.26429","article-title":"Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice","volume":"58","author":"Pradere","year":"2013","journal-title":"Hepatology"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.23337","article-title":"Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity","volume":"51","author":"Stienstra","year":"2010","journal-title":"Hepatology"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/gut.2009.176651","article-title":"Super paramagnetic iron oxide MRI shows defective Kupffer cell uptake function in non-alcoholic fatty liver disease","volume":"59","author":"Asanuma","year":"2010","journal-title":"Gut"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"Gadd","year":"2014","journal-title":"Hepatology"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nri.2017.11","article-title":"Liver macrophages in tissue homeostasis and disease","volume":"17","author":"Krenkel","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hep.23148","article-title":"Immature myeloid cells induced by a high-fat diet contribute to liver inflammation","volume":"50","author":"Deng","year":"2009","journal-title":"Hepatology"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/db09-1403","article-title":"C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis","volume":"59","author":"Obstfeld","year":"2010","journal-title":"Diabetes"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00213.2017","article-title":"CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease","volume":"314","author":"Parker","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/hep4.1139","article-title":"Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice","volume":"2","author":"Friedman","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.molmet.2014.11.001","article-title":"Maternal high-fat diet and obesity compromise fetal hematopoiesis","volume":"4","author":"Krasnow","year":"2015","journal-title":"Mol. Metab."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/MPG.0b013e3181fb47d3","article-title":"Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease","volume":"52","author":"Brunt","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/liv.12024","article-title":"Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease","volume":"33","author":"Alkhouri","year":"2013","journal-title":"Liver Int."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fendo.2017.00349","article-title":"Early microbes modify immune system development and metabolic homeostasis- the \u201cRestaurant\u201d hypothesis revisited","volume":"8","author":"Nash","year":"2017","journal-title":"Front. Endocrinol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.3389\/fimmu.2019.02441","article-title":"Potential role of gut microbiota in induction and regulation of innate immune memory","volume":"10","author":"Negi","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1017\/S0954422418000239","article-title":"Interplay between early-life malnutrition, epigenetic modulation of the immune function and liver diseases","volume":"32","author":"Campisano","year":"2019","journal-title":"Nutr. Res. Rev."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/10\/3166\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:22:25Z","timestamp":1760178145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/10\/3166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":202,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["nu12103166"],"URL":"https:\/\/doi.org\/10.3390\/nu12103166","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,16]]}}}